Diabetes, use of metformin, and the risk of meningioma

BACKGROUND: Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. METHODS: We conducted a matched case-control analysis using data from the U....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S., Proescholdt, Martin, Bogdahn, Ulrich, Hau, Peter, Leitzmann, Michael F.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510861/
https://ncbi.nlm.nih.gov/pubmed/28708856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0181089
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares